Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related ABT
Benzinga's M&A Chatter for Monday February 1, 2015
Mid-Afternoon Market Update: Roper Technologies Falls Following Weak Results; Questar Shares Spike Higher
Recent Buy: Pfizer (Seeking Alpha)
Related PCLN
Priceline Plunges After Goldman Sachs Downgrade
Benzinga's Top Downgrades
TripAdvisor Surprises, Joins Expedia In Bolstering Sector (Investor's Business Daily)

Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday.

Deutsche Bank upgraded priceline.com (NASDAQ: PCLN) from “hold” to “buy.” The target price for priceline.com has been raised from $715 to $900. priceline.com's shares closed at $813.66 on Friday.

Analysts at Maxim Group upgraded J.C. Penney Company (NYSE: JCP) from “hold” to “buy.” The target price for J.C. Penney has been raised from $16.50 to $27. J.C. Penney's shares closed at $18.01 on Friday.

Morgan Stanley upgraded E-Commerce China Dangdang (NYSE: DANG) from “equal-weight” to “overweight.” The target price for E-Commerce China Dangdang has been raised from $5 to $6.50. E-Commerce China Dangdang's shares closed at $5.71 on Friday.

Latest Ratings for ABT

DateFirmActionFromTo
Feb 2016Argus ResearchUpgradesHoldBuy
Jan 2016William BlairDowngradesOutperformMarket Perform
Jan 2016JefferiesMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABT + DANG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters